BioNTech
BNTX
109 hedge funds and large institutions have $1.78B invested in BioNTech in 2020 Q2 according to their latest regulatory filings, with 78 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 6 closing their positions.
1,200% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 6
363% more capital invested
Capital invested by funds: $384M → $1.78B (+$1.39B)
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
195% more funds holding
Funds holding: 37 → 109 (+72)
186% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 7
31% more call options, than puts
Call options by funds: $33.4M | Put options by funds: $25.4M
8.73% more ownership
Funds ownership: 2.92% → 11.65% (+8.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$473M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$145M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$77.5M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$58.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$29.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$11.4M |
| 2 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$5.08M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.17M |
| 4 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$990K |
| 5 |
AWM
Avitas Wealth Management
Los Angeles,
California
|
-$978K |
BNTX Hedge Fund Activity: Q2 2020 in Review
109 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q2 2020, worth a combined $1.78B — up 363% from $384M a quarter earlier.
Buyers outnumbered sellers: 78 funds opened new BNTX positions and 6 closed out — a net gain of 72 holders — while 20 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $473M. The largest seller was Artal Group, cutting an estimated $11.4M.
- 109 institutional investors held BioNTech (BNTX) as of Q2 2020, up from 37 in Q1 2020.
- Funds reported $1.78B of BioNTech stock for Q2 2020, up 363% quarter-over-quarter.
- 78 funds opened new BioNTech positions in Q2 2020 and 6 closed out, a net change of +72 holders.
- The largest BioNTech buyer in Q2 2020 was Fidelity Investments, an estimated $473M added.
- The largest BioNTech seller in Q2 2020 was Artal Group, an estimated $11.4M sold.
Based on aggregated 13F filings for Q2 2020.